Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance

    Antimicrobial Agents and Chemotherapy, pp. 7426-7436, 2015.

    Cited by: 0|Bibtex|Views1|

    Abstract:

    Various protease inhibitors (PIs) currently are becoming available for treatment of hepatitis C virus (HCV). For genotype 1, substitutions at NS3 protease positions 155, 156, and 168 are the main determinants of PI resistance. For other genotypes, similar substitutions were selected during PI treatment but were not characterized systemati...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments